Supernus Pharmaceuticals Competitors and Similar CompaniesClear all

Supernus Pharmaceuticals's competitors and similar companies include Neuraxpharm, moksha8 Pharmaceuticals, Vanda Pharmaceuticals and Intra-Cellular Therapies.
Supernus Pharmaceuticals
Supernus Pharmaceuticals
Supernus Pharmaceuticals is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system disorders.
Neuraxpharm
Neuraxpharm
Neuraxpharm is a pharmaceutical company focusing on the treatment of central nervous system (CNS) disorders.
moksha8 Pharmaceuticals
moksha8 Pharmaceuticals
Moksha8 is a pharmaceutical company which provides therapeutics for the treatment of central nervous system and mental health disorders.
Vanda Pharmaceuticals
Vanda Pharmaceuticals
Vanda Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders.
Intra-Cellular Therapies
Intra-Cellular Therapies
Intra-Cellular Therapies develops drugs for the treatment of neuropsychiatric and neurologic diseases, and other disorders of the CNS.
Founding Date
Founding Date
2005
Founding Date
1985
Founding Date
2006
Founding Date
2002
Founding Date
2002
Type
Type
Public
Type
Private
Type
Private
Type
Public
Type
Public
Tags
Locations
Locations
Rockville, US HQ
Locations
Langenfeld (Rheinland), DE HQ
Gießhübl, AT
Hradec Králové, CZ
Paris, FR
Budapest, HU
Dublin, IE
Ascoli Piceno, IT
see more
Locations
Berwyn, US HQ
Ciudad De México, MX
Locations
Washington, US HQ
Berlin, DE
London, GB
Locations
New York, US HQ
Employees
Employees
5752% increase
Employees
6331% increase
Employees
3572% increase
Employees
2845% increase
Employees
330352% increase
Valuation ($)
Valuation ($)
1.6 b
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
298.6 m
Valuation ($)
6.9 b
Twitter followers
Twitter followers
284
Twitter followers
N/A
Twitter followers
N/A
Twitter followers
913
Twitter followers
N/A

Financial

Revenue (est.)
Revenue (est.)
$667.2m (FY, 2022)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
$192.6m (FY, 2023)
Revenue (est.)
$464.4m (FY, 2023)
Net income
Net income
$60.7m (FY, 2022)
Net income
N/A
Net income
N/A
Net income
$2.5m (FY, 2023)
Net income
($139.7m) (FY, 2023)

Funding

Total funding raised
Total funding raised
$ 69.5m
Total funding raised
N/A
Total funding raised
$ 224.1m
Total funding raised
$ 54m
Total funding raised
$ 225.3m
For sources of this data, please see the company profile

View Company Profiles

Neuraxpharm
HQ
Langenfeld (Rheinland), DE
Employees
633↑ 1% increase

Neuraxpharm is a pharmaceutical company focusing on the treatment of central nervous system (CNS) disorders.

View company
moksha8 Pharmaceuticals
HQ
Berwyn, US
Employees
357↑ 2% increase

Moksha8 is a pharmaceutical company which provides therapeutics for the treatment of central nervous system and mental health disorders.

View company
Vanda Pharmaceuticals
HQ
Washington, US
Employees
284↑ 5% increase

Vanda Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders.

View company
Intra-Cellular Therapies
HQ
New York, US
Employees
330

Intra-Cellular Therapies develops drugs for the treatment of neuropsychiatric and neurologic diseases, and other disorders of the CNS.

View company